Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
I believe that any nation that grants equal opportunity to every citizen, regardless of race, religion, political affiliation, or gender, thereby, establishes its moral legitimacy. According to this principle, Israel stands alone in the Middle East region, as a nation with moral legitimacy: it grants all citizens equal rights for men and women alike, freedom of religion, and freedom of speech and of the press. Not a single Arab or Muslim country in the surrounding region does the same. Nor do any of those Arab and Muslim nations allow their citizens personal freedom, or the right to maintain and express opposing points of view.
These essential qualities of life provide oxygen for the human soul; they are the kind of basic nourishment that is desperately missing in all of Israel's Muslim neighbors. Yet, the so-called humanitarian aid organizations at the United Nations direct all their energy to act against anything and everything Israel does. Let me ask: as every human being deserves to live in dignity, why has an enormous unbalanced portion of global aid gone mostly to Palestinians, while millions of underprivileged people all over the world suffer genuine, life-threatening deprivation? Here is why: The United Nations time and again focuses its power on the perpetual manufacturing of false anti-Israel accusations. Painting Palestinians as perennial underdogs provides the perfect cover for their subversive effort. Without doubt, this trend encourages hatred and violence against the Jewish people in Israel and everywhere else. And that is exactly its point.
A Palestinian women's organization reported that Muslim men perpetrate some 40 honor killings annually in the West Bank alone, not including the vast majority of honor killing and abuse of women that go unreported -- as Islamic society maintains secrecy in upholding the popular belief that those "cursed with a sin, [should] hide it."
According to recent face-to-face surveys by prominent international pollsters, more Palestinians in East Jerusalem would prefer to be citizens of Israel than citizens of a new Palestinian state -- and 40% would probably or definitely move to avoid Palestinian rule.
Those who love liberty and life will strengthen their ties and warm relations with Israel, and stand with her. Israel will continue to shine its light among all nations.
The United Nations and Human Rights Abuse | EuropeNews
As a world leader in science and technology, Israel excels in such areas as genetics, medicine, agriculture, computer sciences, electronics, optics, and engineering. Scientists at Israeli universities such as Bar Ilan University, Ben Gurion University, Haifa University, Hebrew University, The Technion--Israel Institute of Technology, Tel Aviv University and the Weizmann Institute of Science are pioneers in areas such as stem cell-based tissue engineering, nanotechnology, high-resolution electron microscopy, and solar energy. Israeli companies have developed such diverse products as the first anti-virus package, technologies that allow you to leave voice mail on mobile phones, and stents that save lives by keeping the arteries to the heart open.
MISTI MIT-Israel
Last year, Teva's medicines filled nearly 630 million prescriptions in the United States, making it a larger domestic supplier than such pharmaceutical heavyweights as Pfizer, Novartis and Merck — combined. And as low-cost generics continue to make inroads with consumers, Teva occupies a pivotal position in a health care industry undergoing seismic changes that will give millions of more patients access to medicine.
Dozens of popular drugs are also about to lose their patent protections, opening the door to a generic boom. Already the generic industry’s leader, Teva is likely to capture even greater market share, analysts say, because it has cultivated a reputation for producing high-quality, low-cost drugs.
Like a typical generic maker, Teva doesn’t advertise or brand its no-name products. It does, however, supply medications for one out of every six prescriptions dispensed in the United States.
After at least $20 billion in acquisitions over the last decade and heady organic growth, Teva now has a market capitalization of about $53 billion
“There is a culture of excellence at Teva that frankly I don’t see a lot in pharma, period — branded companies, generics, it doesn’t matter,” says Richard B. Silver, an analyst at Barclays Capital who has been covering Teva since 1993. “They just do it better. That’s all.”
http://www.nytimes.com/2010/05/09/business/09teva.html?pagewanted=all
Israel is by many measures the country, relative to its population, that's done the most to contribute to the technology revolution
If you go to the Middle East looking for oil, you don't even stop at Israel. But, if you go looking for brains, for energy and for integrity, Israel is the only stop you make.
[ame=http://www.youtube.com/watch?v=zHStBGk_D8Y]Israel Innovation - YouTube[/ame]When you look at the NASDAQ, companies are listed from around the world. There's one country, though, that truly stands out and that is Israel
A delegation of 60 British top academics are visiting Israel this week to launch a groundbreaking programme to promote collaboration between the two countries in regenerative medicine as part of the Britain-Israel Research and Academic Exchange Partnership (BIRAX)
BIRAX was originally designed by the British Council in Israel in 2008 in collaboration with Pears Foundation and academic leaders from both countries. It was launched by the British and Israeli prime ministers with the aim of enhancing research and academic cooperation, creating new institutional links for the future and strengthening academic links between universities in the UK and Israel.
Over 250 people will participate in the first UK-Israel Regenerative Medicine Conference at Ben-Gurion University of the Negev on 22-23 November, with millions of people who have suffered major trauma, heart disease and Parkinsons disease standing to benefit from this first-ever gathering of specialists.
Regenerative Medicine aims to restore the function of tissues and organs using a variety of approaches including cell therapy, tissue engineering, gene therapy and biomedical engineering. Both Israel and the UK are recognised as world leaders in this cutting-edge area of medicine.
Matthew Gould, British Ambassador to Israel, said: Britain and Israel are natural partners in regenerative medicine. The UK is a world leader in science we have four of the worlds top ten universities and Israe lis a scientific powerhouse. We can achieve much more together than we can apart. My hope is that this conference leads to a surge of collaborations between British and Israeli scientists, with the UK-Israel Regenerative Medicine programme stimulating ground-breaking research projects.
Trevor Pears, Executive Chair of Pears Foundation said: We are delighted to see our partnership with the British Council and the British Government continue to deepen academic cooperation and research between Britain and Israel. We hope that these links will continue to grow and flourish for the benefit of Britain, Israel and the world.
British and Israeli experts collaborate on finding cures for major diseases « Pears Foundation
While we wait and hope for a diabetes cure, we make the most of the technology that helps us manage our disease. Fortunately, the technology keeps getting better. Earlier this month we reported the exciting news about the worlds first out-of-hospital artificial pancreas trial. The trial, conducted byProfessor Moshe Phillip and his team at the Institute of Endocrinology and Diabetes at Schneider Childrens Medical Center of Israel and Eran Atlas, head of the engineering team at the Diabetes Technology Institute at Schneider Childrens, took place on Kibbutz Maale Hahamisha in the hills outside of Jerusalem.
Eighteen children with type 1 diabetes participated in this experiment, which utilized the MD-Logic system developed at Schneider Childrens. The MD-Logic system allows real-time control of the blood glucose levels based on readings from a continuous glucose sensor. It is based on a model which imitates the logic of diabetes caregivers.
Israeli Hospital Invents Revolutionary Artificial PancreasThe Artificial Pancreas in Action: Must See Video
While we wait and hope for a diabetes cure, we make the most of the technology that helps us manage our disease. Fortunately, the technology keeps getting better. Earlier this month we reported the exciting news about the worlds first out-of-hospital artificial pancreas trial. The trial, conducted byProfessor Moshe Phillip and his team at the Institute of Endocrinology and Diabetes at Schneider Childrens Medical Center of Israel and Eran Atlas, head of the engineering team at the Diabetes Technology Institute at Schneider Childrens, took place on Kibbutz Maale Hahamisha in the hills outside of Jerusalem.
Eighteen children with type 1 diabetes participated in this experiment, which utilized the MD-Logic system developed at Schneider Childrens. The MD-Logic system allows real-time control of the blood glucose levels based on readings from a continuous glucose sensor. It is based on a model which imitates the logic of diabetes caregivers.
"We Desire Death Like You Desire Life"
[ame=http://www.youtube.com/watch?v=CWIDZ7Jpdqg]Hamas - "We desire death like you desire life" - YouTube[/ame]
